<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>52</patient-age><report-id>JP-VERTEX PHARMACEUTICAL INC.-AE-2012-009043</report-id><gender>female</gender><reactions><reaction>WBC DECREASED</reaction><reaction>NEUTROPHIL DECREASED</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>VX-950 (Telaprevir)</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>REBETOL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PEGINTRON</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>URSO                               /00465701/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>GASTER D</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>NABOAL                             /00372302/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>ALOSENN                            /00476901/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>VOLTAREN                           /00372301/</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LAXOBERON</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Chronic hepatitis C</indication></indications><patient-age>52</patient-age><outcomes/><country>Japan</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>30724_111</messagenumb>
		<messagesenderidentifier>VERTEXP2</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125151729</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>4</safetyreportversion>
		<safetyreportid>JP-VERTEX PHARMACEUTICAL INC.-AE-2012-009043</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>2</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-06-14</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-17</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>JP-Vertex Pharmaceuticals Inc.-AE-2012-009043</companynumb>
		<duplicate>1</duplicate>
		<reportduplicate>
			<duplicatesource>Vertex Pharmaceuticals Inc.</duplicatesource>
			<duplicatenumb>JP-Vertex Pharmaceuticals Inc.-AE-2012-009043</duplicatenumb>
		</reportduplicate>
		<primarysource>
			<reporterfamilyname>UNKNOWN</reporterfamilyname>
			<reportercountry>JP</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
			<studyname>Drug Use-Results surveillance</studyname>
			<sponsorstudynumb>Drug Use-Results Surveillance</sponsorstudynumb>
			<observestudytype>3</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>VERTEXP2</senderorganization>
			<senderdepartment>Global Patient Safety</senderdepartment>
			<sendertitle>Mr.</sendertitle>
			<sendergivename>Sean</sendergivename>
			<senderfamilyname>Darcy</senderfamilyname>
			<senderstreetaddress>130 Waverly Street</senderstreetaddress>
			<sendercity>Cambridge</sendercity>
			<senderstate>MA</senderstate>
			<senderpostcode>02139</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<senderemailaddress>VRTXGPS_SubmissionTracking@vrtx.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>Office of Surveillence and Epidemiology</receiverdepartment>
			<receivertitle>Mr.</receivertitle>
			<receivergivename>Roger</receivergivename>
			<receiverfamilyname>Goetsch</receiverfamilyname>
			<receiverstreetaddress>8201 Corporate Drive, Suite 540</receiverstreetaddress>
			<receivercity>Landover</receivercity>
			<receiverstate>MD</receiverstate>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>3019189580</receivertel>
			<receivertelextension>194</receivertelextension>
			<receiverfax>3019183134</receiverfax>
			<receiveremailaddress>roger.goetsch@fda.hhs.gov</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>Y-I</patientinitial>
			<patientonsetage>52</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Chronic hepatitis C</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Gastritis</patientepisodename>
				<patientmedicalcontinue>1</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Insomnia</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>WBC DECREASED</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>WBC decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>White blood cell count decreased</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120505</reactionstartdate>
				<reactionfirsttime>17</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>NEUTROPHIL DECREASED</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Neutrophil count decreased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Neutrophil count decreased</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120428</reactionstartdate>
				<reactionfirsttime>10</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120418</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1410</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120425</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1840</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120502</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1890</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120509</testdate>
				<testname>Neutrophil count</testname>
				<testresult>920</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120516</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1500</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120523</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1250</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120530</testdate>
				<testname>Neutrophil count</testname>
				<testresult>830</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120606</testdate>
				<testname>Neutrophil count</testname>
				<testresult>2760</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120613</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1630</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120620</testdate>
				<testname>Neutrophil count</testname>
				<testresult>940</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120627</testdate>
				<testname>Neutrophil count</testname>
				<testresult>640</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120704</testdate>
				<testname>Neutrophil count</testname>
				<testresult>610</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120711</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1010</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120808</testdate>
				<testname>Neutrophil count</testname>
				<testresult>810</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120905</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1670</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120926</testdate>
				<testname>Neutrophil count</testname>
				<testresult>1100</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120418</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>29.0</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120425</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>35.8</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120502</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>37.4</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120509</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>29.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120516</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>43.9</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120523</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>37.3</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120530</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>37.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120606</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>69.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120613</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>53.6</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120620</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>43.5</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120627</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>33.4</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120704</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>31.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120711</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>41.0</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120808</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>31.1</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120905</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>48.5</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120926</testdate>
				<testname>Neutrophil percentage</testname>
				<testresult>42.4</testresult>
				<testunit>%</testunit>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120418</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>4840</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120425</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>5130</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120502</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>5060</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120509</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3160</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120516</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3410</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120523</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3360</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120530</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2250</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120606</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>4000</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120613</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3050</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120620</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2150</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120627</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>1910</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120704</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>1980</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120711</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2480</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120808</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2600</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120905</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>3430</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120926</testdate>
				<testname>Leukocyte count NOS</testname>
				<testresult>2600</testresult>
				<testunit>N/A</testunit>
				<moreinformation>1</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>VX-950 (Telaprevir)</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationnumb>201917</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Vertex Pharmaceuticals Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>2250</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugcumulativedosagenumb>40500</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>2250 mg, qd</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic hepatitis C</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-18</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-05-22</drugenddate>
				<drugtreatmentduration>35</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>VX-950</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>VX-950 (Telaprevir)</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationnumb>201917</drugauthorizationnumb>
				<drugauthorizationcountry>US</drugauthorizationcountry>
				<drugauthorizationholder>Vertex Pharmaceuticals Inc.</drugauthorizationholder>
				<drugstructuredosagenumb>1500</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugcumulativedosagenumb>40500</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>1500 mg, qd</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-05-23</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-07-11</drugenddate>
				<drugtreatmentduration>50</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>VX-950</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neutrophil count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>White blood cell count decreased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugresult>Related</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>REBETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>600</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugcumulativedosagenumb>10800</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>600 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic hepatitis C</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-18</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-05-15</drugenddate>
				<drugtreatmentduration>28</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RIBAVIRIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>REBETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugcumulativedosagenumb>10800</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>200 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-05-16</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-08-17</drugenddate>
				<drugtreatmentduration>94</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RIBAVIRIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>REBETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>400</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugcumulativedosagenumb>10800</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="003">milligrams</drugcumulativedosageunit>
				<drugdosagetext>400 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-08-18</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-10-02</drugenddate>
				<drugtreatmentduration>46</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>RIBAVIRIN</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PEGINTRON</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>1.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="008"/>
				<drugdosagetext>1.5 습g/kg, UNK</drugdosagetext>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Chronic hepatitis C</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-18</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-07-04</drugenddate>
				<drugtreatmentduration>78</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PEGINTERFERON ALFA-2B</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>PEGINTRON</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit code="008"/>
				<drugdosagetext>1.0 습g/kg, UNK</drugdosagetext>
				<drugadministrationroute code="058">Subcutaneous</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-07-11</drugstartdate>
				<drugstartperiod>17</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-09-26</drugenddate>
				<drugtreatmentduration>78</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PEGINTERFERON ALFA-2B</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>URSO                               /00465701/</medicinalproduct>
				<drugstructuredosagenumb>600</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>600 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>URSODEOXYCHOLIC ACID</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>GASTER D</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>2</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugcumulativedosagenumb>36</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="032"/>
				<drugdosagetext>2 DF, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-18</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-10-02</drugenddate>
				<drugtreatmentduration>168</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FAMOTIDINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>GASTER D</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugstructuredosagenumb>40</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugcumulativedosagenumb>36</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="032"/>
				<drugdosagetext>40 mg, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-10-02</drugenddate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>FAMOTIDINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>NABOAL                             /00372302/</medicinalproduct>
				<drugdosagetext>UNK UNK, prn</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-18</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-06-06</drugenddate>
				<drugtreatmentduration>50</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DICLOFENAC SODIUM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>ALOSENN                            /00476901/</medicinalproduct>
				<drugstructuredosagenumb>.5</drugstructuredosagenumb>
				<drugstructuredosageunit code="002">grams</drugstructuredosageunit>
				<drugcumulativedosagenumb>.5</drugcumulativedosagenumb>
				<drugcumulativedosageunit code="002">grams</drugcumulativedosageunit>
				<drugdosagetext>0.5 g, qd</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-04-18</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-04-18</drugenddate>
				<drugtreatmentduration>1</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>ACHILLEA MILLEFOLIUM</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>RUBIA TINCTORUM ROOT TINCTURE</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SENNA ALEXANDRINA FRUIT</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>SENNA ALEXANDRINA LEAF</activesubstancename>
				</activesubstance>
				<activesubstance>
					<activesubstancename>TARAXACUM OFFICINALE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>VOLTAREN                           /00372301/</medicinalproduct>
				<drugstructuredosagenumb>1</drugstructuredosagenumb>
				<drugstructuredosageunit code="032"/>
				<drugdosagetext>1 DF, prn</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-06-06</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-10-02</drugenddate>
				<drugtreatmentduration>119</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>DICLOFENAC</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>LAXOBERON</medicinalproduct>
				<drugdosagetext>UNK, prn</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-08-08</drugstartdate>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-08-22</drugenddate>
				<drugtreatmentduration>15</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>SODIUM PICOSULFATE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>The following is a verbatim narrative received from Mitsubishi Tanabe Pharma Corporation:A 52-year old female patient was treated with TELAVIC for <Semaphore x="3000762" class="MedDRA LLT" value="Hepatitis C" score="1.00" ID="10019744"><Semaphore x="1779129" class="Disease or Finding" value="Chronic Hepatitis" score="1.00" ID="C82978">chronic <Semaphore x="2020151" class="Disease or Finding" value="Hepatitis C Infection" score="1.00" ID="C3098">hepatitis </Semaphore></Semaphore>
     <Semaphore x="2020151" class="Disease or Finding" value="Hepatitis C Infection" score="1.00" ID="C3098">C </Semaphore></Semaphore><Semaphore x="2690868" class="Disease or Finding" value="Viremia" score="1.00" ID="C35125">viremia</Semaphore>.The patient had received monotherapy with interferon.18 Apr.2012 <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Therapy </Semaphore>with TELAVIC (2250 mg/day), <Semaphore x="1121709" class="Medicine" value="Rebetol" score="0.93" ID="258409">REBETOL </Semaphore>(600 mg/day), and <Semaphore x="1002429" class="Medicine" value="Pegintron" score="0.93" ID="269821">PEGINTRON </Semaphore>(1.5 mcg/kg/week) was started.21 Apr.2012 UA increased 1 and UA increased 2 were observed.27 Apr.2012 The patient complained of <Semaphore x="2895923" class="MedDRA LLT" value="Decreased appetite" score="1.00" ID="10061428">appetite <Semaphore x="2895923" class="MedDRA LLT" value="Decreased appetite" score="1.00" ID="10061428">impaired </Semaphore>1 and <Semaphore x="2895923" class="MedDRA LLT" value="Decreased appetite" score="1.00" ID="10061428">appetite </Semaphore>impaired </Semaphore>2 (without particular <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>).28 Apr.2012 Neutrophil decreased 1, neutrophil <Semaphore x="3189557" class="MedDRA LLT" value="Platelet count decreased" score="1.00" ID="10035528">decreased 2, <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">platelets </Semaphore><Semaphore x="3189557" class="MedDRA LLT" value="Platelet count decreased" score="1.00" ID="10035528">decreased </Semaphore>1, and <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">platelets </Semaphore>decreased </Semaphore>2 were observed.5 May.2012 <Semaphore x="2986538" class="MedDRA LLT" value="Haemoglobin decreased" score="1.00" ID="10018884">Hb <Semaphore x="2986538" class="MedDRA LLT" value="Haemoglobin decreased" score="1.00" ID="10018884">decreased </Semaphore>1, <Semaphore x="2986538" class="MedDRA LLT" value="Haemoglobin decreased" score="1.00" ID="10018884">Hb </Semaphore><Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">decreased </Semaphore></Semaphore>
    <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">2, <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>decreased 1, and <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>decreased </Semaphore>2 were observed.16 May.2012 The dose of <Semaphore x="1121709" class="Medicine" value="Rebetol" score="0.93" ID="258409">REBETOL </Semaphore>was changed (200 mg/day).23 May.2012 The dose of TELAVIC was <Semaphore x="2812482" class="MedDRA LLT" value="Blood magnesium decreased" score="1.00" ID="10005654">reduced to 1500 mg </Semaphore>per day.Unknown date <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292"><Semaphore x="3057951" class="MedDRA LLT" value="Laboratory test" score="1.00" ID="10059938">Laboratory test </Semaphore>results </Semaphore>showed fluctuations in laboratory data, and the dose of only <Semaphore x="1121709" class="Medicine" value="Rebetol" score="0.93" ID="258409">REBETOL </Semaphore>was reduced to deal with it.4 Jul.2012 Neutrophil decreased had exacerbated. The dose of <Semaphore x="1002429" class="Medicine" value="Pegintron" score="0.93" ID="269821">PEGINTRON </Semaphore>was reduced. <Semaphore x="2895923" class="MedDRA LLT" value="Decreased appetite" score="1.00" ID="10061428">Appetite impaired </Semaphore>2 had resolved.11 Jul.2012 The dose of <Semaphore x="1002429" class="Medicine" value="Pegintron" score="0.93" ID="269821">PEGINTRON </Semaphore>(1.0 mcg/kg/week) was changed. <Semaphore x="3189557" class="MedDRA LLT" value="Platelet count decreased" score="1.00" ID="10035528"><Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">Platelets </Semaphore>decreased </Semaphore>1 had resolved.18 Jul.2012 UA increased 1, and UA increased 2 had resolved.Unknown date <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">Neutrophil count</Semaphore>, Plt, and UA <Semaphore x="779631" class="Medicine" value="Level" score="0.49" ID="187620">level </Semaphore>had recovered as mentioned above.24 Jul.2012 <Semaphore x="2986538" class="MedDRA LLT" value="Haemoglobin decreased" score="1.00" ID="10018884">Hb <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">decreased </Semaphore></Semaphore>
    <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">2, <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>decreased </Semaphore>2, neutrophil <Semaphore x="3189557" class="MedDRA LLT" value="Platelet count decreased" score="1.00" ID="10035528">decreased 2, and <Semaphore x="2406620" class="Procedure" value="Platelet Count" score="1.00" ID="C51951">platelets </Semaphore>decreased </Semaphore>2 were ongoing.8 Aug.2012 The patient experienced <Semaphore x="2059169" class="Disease or Finding" value="Insomnia due to Organic Factor" score="1.00" ID="C35647">insomnia</Semaphore>. The patient complained of <Semaphore x="3043024" class="MedDRA LLT" value="Insomnia" score="1.00" ID="10022437">sleep loss</Semaphore>. LENDORMIN D (0.25 mg/day, until 22 Aug., <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) was prescribed.18 Aug.2012 The dose of <Semaphore x="1121709" class="Medicine" value="Rebetol" score="0.93" ID="258409">REBETOL </Semaphore>was changed to 400 mg per day.29 Aug.2012 DEPAS (0.5 mg/day, until 2 Oct., <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) was administered additionally. Thereafter it was <Semaphore x="1854518" class="Disease or Finding" value="Disease Controlled" score="1.00" ID="C82500">under <Semaphore x="1854518" class="Disease or Finding" value="Disease Controlled" score="1.00" ID="C82500">control</Semaphore></Semaphore>.26 Sep.2012 <Semaphore x="2986538" class="MedDRA LLT" value="Haemoglobin decreased" score="1.00" ID="10018884">Hb <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">decreased</Semaphore></Semaphore>
    <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">, <Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>decreased</Semaphore>, and neutrophil decreased were ongoing. The administration of <Semaphore x="1002429" class="Medicine" value="Pegintron" score="0.93" ID="269821">PEGINTRON </Semaphore>was completed.2 Oct.2012 <Semaphore x="2059169" class="Disease or Finding" value="Insomnia due to Organic Factor" score="1.00" ID="C35647">Insomnia </Semaphore>had resolved.Reporter's comment Low <Semaphore x="3321117" class="MedDRA LLT" value="White blood cell count" score="1.00" ID="10047939"><Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>count </Semaphore>was persisting. Even as of 10 Dec.2012, it was still at a low count of 3530.Follow up information:Events "neutrophil <Semaphore x="3320985" class="MedDRA LLT" value="White blood cell count decreased" score="1.00" ID="10047942">decreased 2" and "<Semaphore x="2110173" class="Procedure" value="Leukocyte Count" score="1.00" ID="C51948">WBC </Semaphore>decreased </Semaphore>2" were deleted. Patient information, <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>information, clinical course, laboratory data, and reporter's comment were updated.</narrativeincludeclinical>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>